Status:
ACTIVE_NOT_RECRUITING
PURI-PRO - Symptoms Impact and eHealth Intervention for Menopausal Women With Urinary Incontinence
Lead Sponsor:
ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida
Collaborating Sponsors:
Fundação para a Ciência e a Tecnologia
Conditions:
Urinary Incontinence
Eligibility:
FEMALE
40-65 years
Phase:
NA
Brief Summary
Urinary Incontinence (UI) is a public health problem that disrupts the Quality of Life, Productivity, Social Isolation and Sexual Function; its prevalence in peri- and postmenopausal women is around 3...
Detailed Description
PURI-PRO's intervention followed an experimental design (randomised controlled trial) involving UI intervention (Experimental Group-EG) vs. Health Literacy single-leaflet (Control Group-CG), both deli...
Eligibility Criteria
Inclusion
- Age (40-65 years);
- Sex (women);
- The presence of UI (positive response to a question about experiencing involuntary urine loss during intra-abdominal pressure increment and/or when feeling an incontrollable urge to urinate, occasionally or frequently);
- Internet access.
Exclusion
- Pregnancy or delivery in the past 6 months;
- Previous UI-related surgery;
- History of pelvic prolapse:
- Known malignancy in the lower abdomen;
- Neurological disease that could affect bladder control;
- Substance use disorder.
Key Trial Info
Start Date :
April 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06527638
Start Date
April 22 2025
End Date
January 1 2026
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISPA-IU
Lisbon, Portugal